189 related articles for article (PubMed ID: 17260005)
1. Prominent contribution of portal mesenchymal cells to liver fibrosis in ischemic and obstructive cholestatic injuries.
Beaussier M; Wendum D; Schiffer E; Dumont S; Rey C; Lienhart A; Housset C
Lab Invest; 2007 Mar; 87(3):292-303. PubMed ID: 17260005
[TBL] [Abstract][Full Text] [Related]
2. Proliferation and phenotypic modulation of portal fibroblasts in the early stages of cholestatic fibrosis in the rat.
Tuchweber B; Desmoulière A; Bochaton-Piallat ML; Rubbia-Brandt L; Gabbiani G
Lab Invest; 1996 Jan; 74(1):265-78. PubMed ID: 8569191
[TBL] [Abstract][Full Text] [Related]
3. Extracellular matrix deposition, lysyl oxidase expression, and myofibroblastic differentiation during the initial stages of cholestatic fibrosis in the rat.
Desmoulière A; Darby I; Costa AM; Raccurt M; Tuchweber B; Sommer P; Gabbiani G
Lab Invest; 1997 Jun; 76(6):765-78. PubMed ID: 9194853
[TBL] [Abstract][Full Text] [Related]
4. Effect of the transdifferentiation of BECs into myofibroblasts on the pathogenesis of secondary cholestatic hepatic fibrosis.
Qiu BF; Zhang GQ; Xu FM; Xu Q; Xu T
Exp Ther Med; 2019 Apr; 17(4):2769-2776. PubMed ID: 30906466
[TBL] [Abstract][Full Text] [Related]
5. Portal myofibroblasts are sensitive to CCN-mediated endoplasmic reticulum stress-related apoptosis with potential to attenuate biliary fibrogenesis.
Borkham-Kamphorst E; Steffen BT; van de Leur E; Haas U; Weiskirchen R
Cell Signal; 2018 Nov; 51():72-85. PubMed ID: 30044965
[TBL] [Abstract][Full Text] [Related]
6. The myofibroblastic conversion of peribiliary fibrogenic cells distinct from hepatic stellate cells is stimulated by platelet-derived growth factor during liver fibrogenesis.
Kinnman N; Francoz C; Barbu V; Wendum D; Rey C; Hultcrantz R; Poupon R; Housset C
Lab Invest; 2003 Feb; 83(2):163-73. PubMed ID: 12594232
[TBL] [Abstract][Full Text] [Related]
7. Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers.
Cassiman D; Libbrecht L; Desmet V; Denef C; Roskams T
J Hepatol; 2002 Feb; 36(2):200-9. PubMed ID: 11830331
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor-α promotes cholestasis-induced liver fibrosis in the mouse through tissue inhibitor of metalloproteinase-1 production in hepatic stellate cells.
Osawa Y; Hoshi M; Yasuda I; Saibara T; Moriwaki H; Kozawa O
PLoS One; 2013; 8(6):e65251. PubMed ID: 23755201
[TBL] [Abstract][Full Text] [Related]
9. Hepatic stellate cell proliferation is an early platelet-derived growth factor-mediated cellular event in rat cholestatic liver injury.
Kinnman N; Goria O; Wendum D; Gendron MC; Rey C; Poupon R; Housset C
Lab Invest; 2001 Dec; 81(12):1709-16. PubMed ID: 11742041
[TBL] [Abstract][Full Text] [Related]
10. Anti-fibrotic effects of fresh and cryopreserved human amniotic membrane in a rat liver fibrosis model.
Ricci E; Vanosi G; Lindenmair A; Hennerbichler S; Peterbauer-Scherb A; Wolbank S; Cargnoni A; Signoroni PB; Campagnol M; Gabriel C; Redl H; Parolini O
Cell Tissue Bank; 2013 Sep; 14(3):475-88. PubMed ID: 22926336
[TBL] [Abstract][Full Text] [Related]
11. Adaptative bile duct proliferative response in experimental bile duct ischemia.
Beaussier M; Wendum D; Fouassier L; Rey C; Barbu V; Lasnier E; Lienhart A; Scoazec JY; Rosmorduc O; Housset C
J Hepatol; 2005 Feb; 42(2):257-65. PubMed ID: 15664253
[TBL] [Abstract][Full Text] [Related]
12. Accumulation of citrullinated glial fibrillary acidic protein in a mouse model of bile duct ligation-induced hepatic fibrosis.
Kim SE; Park JW; Kim MJ; Jang B; Jeon YC; Kim HJ; Ishigami A; Kim HS; Suk KT; Kim DJ; Park CK; Choi EK; Jang MK
PLoS One; 2018; 13(8):e0201744. PubMed ID: 30071078
[TBL] [Abstract][Full Text] [Related]
13. Amniotic membrane application reduces liver fibrosis in a bile duct ligation rat model.
Sant'Anna LB; Cargnoni A; Ressel L; Vanosi G; Parolini O
Cell Transplant; 2011; 20(3):441-53. PubMed ID: 20719087
[TBL] [Abstract][Full Text] [Related]
14. Origin of myofibroblasts in the fibrotic liver in mice.
Iwaisako K; Jiang C; Zhang M; Cong M; Moore-Morris TJ; Park TJ; Liu X; Xu J; Wang P; Paik YH; Meng F; Asagiri M; Murray LA; Hofmann AF; Iida T; Glass CK; Brenner DA; Kisseleva T
Proc Natl Acad Sci U S A; 2014 Aug; 111(32):E3297-305. PubMed ID: 25074909
[TBL] [Abstract][Full Text] [Related]
15. Biliary intervention aggravates cholestatic liver injury, and induces hepatic inflammation, proliferation and fibrogenesis in BDL mice.
Wen YA; Liu D; Zhou QY; Huang SF; Luo P; Xiang Y; Sun S; Luo D; Dong YF; Zhang LP
Exp Toxicol Pathol; 2011 Mar; 63(3):277-84. PubMed ID: 20149605
[TBL] [Abstract][Full Text] [Related]
16. Transient expression of tenascin in experimentally induced cholestatic fibrosis in rat liver: an immunohistochemical study.
Miyazaki H; Van Eyken P; Roskams T; De Vos R; Desmet VJ
J Hepatol; 1993 Nov; 19(3):353-66. PubMed ID: 7512109
[TBL] [Abstract][Full Text] [Related]
17. Endoplasmic reticulum stress induces inverse regulations of major functions in portal myofibroblasts during liver fibrosis progression.
Loeuillard E; El Mourabit H; Lei L; Lemoinne S; Housset C; Cadoret A
Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3688-3696. PubMed ID: 30292633
[TBL] [Abstract][Full Text] [Related]
18. Induction of Obstructive Cholestasis in Mice.
Weiskirchen R; Weiskirchen S; Tag CG; Meurer SK
Methods Mol Biol; 2023; 2669():163-175. PubMed ID: 37247059
[TBL] [Abstract][Full Text] [Related]
19. In vivo responses of macrophages and perisinusoidal cells to cholestatic liver injury.
Hines JE; Johnson SJ; Burt AD
Am J Pathol; 1993 Feb; 142(2):511-8. PubMed ID: 8434646
[TBL] [Abstract][Full Text] [Related]
20. Rapamycin ameliorates inflammation and fibrosis in the early phase of cirrhotic portal hypertension in rats through inhibition of mTORC1 but not mTORC2.
Wang W; Yan J; Wang H; Shi M; Zhang M; Yang W; Peng C; Li H
PLoS One; 2014; 9(1):e83908. PubMed ID: 24404143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
